MISTRAS Group Continues To Innovate Pipeline Integrity Inspection Technology
29. April 2022 13:00 ET
|
MISTRAS Group, Inc.
PRINCETON JUNCTION, N.J., April 29, 2022 (GLOBE NEWSWIRE) -- MISTRAS Group (NYSE: MG) is pleased to announce recent innovative technological advancements to its integrated pipeline integrity and...
MISTRAS Group Acquires New Century Software, a Leading Pipeline Data Management Provider
04. September 2019 16:01 ET
|
Mistras Group Inc
PRINCETON JUNCTION, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- MISTRAS Group (NYSE: MG) – a leading, “one source” global provider of technology-enabled asset protection solutions used to maximize the...
ARTICLE COMPARING SURVIVAL OUTCOMES OF ISOLATED LIMB INFUSION VERSUS PV-10 FOR IN-TRANSIT MELANOMA PUBLISHED IN JOURNAL OF SURGICAL ONCOLOGY
29. Januar 2019 08:30 ET
|
Provectus Biopharmaceuticals Inc.
- 72 patients were treated with either ILI or PV-10 at Australia’s Princess Alexandra Hospital; data were prospectively recorded; primary outcome was melanoma-specific survival; ILI is historical...